Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2008
07/03/2008WO2008080120A2 3-amino chromane derivatives
07/03/2008WO2008080045A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders
07/03/2008WO2008080015A2 Compounds and methods for kinase modulation, and indications therefor
07/03/2008WO2008080001A2 Compounds and methods for kinase modulation, and indications therefor
07/03/2008WO2008079721A1 Alpha-2 receptor pan agonist and serotonin-norepinephrine reuptake inhibitor compositions for treating chronic pain
07/03/2008WO2008079683A2 N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
07/03/2008WO2008079570A1 Spirocyclic azaadamantane derivatives and methods of use
07/03/2008WO2008079408A1 A zebrafish based screen for agents with ability to prevent cell death
07/03/2008WO2008079387A1 Catechol protected levodopa diester prodrugs, compositions, and methods of use
07/03/2008WO2008079346A1 5-cyan0-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/03/2008WO2008078837A1 2-substituted-6-heterocyclic pyrimidone derivatives as tau protein kinase 1 inhbitors
07/03/2008WO2008078826A1 Therapeutic agent for diabetic neuropathy
07/03/2008WO2008078730A1 Preparation for transnasal application
07/03/2008WO2008078179A1 Trkb agonists for treating autoimmune disorders
07/03/2008WO2008077811A1 Spiro-piperidine derivatives
07/03/2008WO2008077625A1 Heterocyclyl-substituted-ehylamino-phenyl derivatives, their preparation and use as medicaments
07/03/2008WO2008077557A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists
07/03/2008WO2008077404A1 Substituted acetophenones useful as pde4 inhibitors
07/03/2008WO2008077277A1 Process for preparation of spider lyophilizate and use in medicaments and functional foods
07/03/2008WO2008077276A1 An injectable solution of spider venom and preparation thereof
07/03/2008WO2008077236A1 Adp-ribosyl transferase fusion variant proteins
07/03/2008WO2008077234A1 Synergistic effects of c3, cyclic amp and ciliary neurotrophic factor on neuronal survival and axonal regeneration
07/03/2008WO2008056059A3 4-azasterol derivatives, methods for the synthesis thereof and use of same as drugs
07/03/2008WO2008024980A3 Pyrrole, thiophene, furan, imidazole, oxazole, and thiazole derivatives
07/03/2008WO2008002596A3 Adenosine a2a receptor antagonists
07/03/2008WO2007100652A3 Side chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
07/03/2008US20080161562 2-(6-Chloro-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl)-benzonitrile
07/03/2008US20080161426 p53 Inhibitors and Therapeutic Use of the Same
07/03/2008US20080161419 Selective antagonistic compounds 5-HT2B and 5-HT7 receptors; reduced side effects
07/03/2008US20080161406 Novel formulations of alpha-2,4-disulfophenyl-N-tert-butylnitrone
07/03/2008US20080161402 Targeting the Reverse Mode of the Na+/Ca2+ Exchanger For the Treatment of Neurodegenerative Conditions
07/03/2008US20080161400 Use of forms of propofol for treating diseases associated with oxidative stress
07/03/2008US20080161393 e.g. 1-{[( alpha -isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid; migraine, fibromyalgia, amyotrophic lateral sclerosis, irritable bowel syndrome, social phobia, Parkinson's disease, asthma, cough, or chronic obstructive pulmonary disease; sustained release
07/03/2008US20080161391 Novel curcumin analogues and uses thereof
07/03/2008US20080161378 e.g. 3-methyl-1-phenyl-2-pyrazolin-5-one; generic name: "Edaravone" commercial name: "Radicut" (used as a cerebroprotective agent), when its dose regimens, dosages and administration periods are changed
07/03/2008US20080161371 Modulators of cystic fibrosis transmembrane conductance regulator
07/03/2008US20080161366 Aminoalkyl substituted aryl sulfamide derivatives and methods of their use
07/03/2008US20080161357 Devices and methods for pain management
07/03/2008US20080161356 Precise, long duration; metered systemic delivery of sufentanil; minimizing tissue trauma; reducing gastrointestinal and respiratory system side effects
07/03/2008US20080161354 Stable s-nitrosothiols, method of synthesis and use
07/03/2008US20080161353 8-Hydroxy quinoline derivatives
07/03/2008US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example
07/03/2008US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer
07/03/2008US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080161323 Piperazine Derivatives of Alkyl Oxindoles
07/03/2008US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease
07/03/2008US20080161316 Indoles
07/03/2008US20080161315 Indoles
07/03/2008US20080161314 Novel Diazabicyclic Aryl Derivatives and Their Medical Use
07/03/2008US20080161312 Derivatives of Pyrrolo-Pyrazines Having a Kinase Inhibitory Activity and Their Biological Applications
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008US20080161309 Novel Compounds
07/03/2008US20080161304 e.g. 1'-(1-Benzothien-2-ylcarbonyl)-3H-spiro[2-benzofuran-1,4'-piperidine]; vasopressin receptor antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome, obsessive compulsive disorder
07/03/2008US20080161301 2-Oxy-Benzoxazinone Derivatives for the Treatment of Obesity
07/03/2008US20080161298 Spiro-piperidine derivatives
07/03/2008US20080161289 6-Cyclobutyl-2-[4-(trifluoromethyl)phenyl]-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[4,5-d]azepine; neurological and psychiatric disorders
07/03/2008US20080161281 Amino-Substituted Tricyclic Derivatives and Methods of Use
07/03/2008US20080161277 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
07/03/2008US20080161269 Compounds 620
07/03/2008US20080161267 Mitoquinone Derivatives Used as Mitochondrially Targeted Antioxidants
07/03/2008US20080161257 Oligonucleotide-Containing Pharmacological Compositions And Their Use
07/03/2008US20080161240 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
07/03/2008US20080161226 Activatable Clostridial Toxins
07/03/2008US20080160617 Agent for inducing embryonic stem cell to ectodermal cell, method for obtaining the same, and use of the same
07/03/2008US20080160121 Identifying an epileptogenic focus of a patient; and administering a botulinum toxin; direct infusion, circumventing the blood-brain barrier
07/03/2008US20080160074 three-dimensional synthetic and semi-synthetic compositions having biological activity, such as liposomes, beads or similar particles; anti-inflammatory, organ protective and immune regulatory effects
07/03/2008US20080160033 Novel Screening Method
07/03/2008US20080160028 Phosphodiesterase-4 (PDE-4) inhibitors; for treating bronchial asthma, COPD, rheumatoid arthritis (RA), osteoarthritis, cystic fibrosis, Guillain-Barresyndrome, Crohn's disease, ulcerative colitis, psoriasis, atopic dermatitis, allergic eczemas
07/03/2008US20080160022 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
07/03/2008US20080160018 Using mik- beta 1 monoclonal antibody as therapeutic tool in treatment and prevention of graft vs. host, autoimmune and diabetic disorders
07/03/2008US20080160006 Nutrient broth for maintenance of brain or spinal cord tissue
07/03/2008US20080159999 Cell differentiation; transfection; gene therapy; tissue engineering; Alzheimer's disease, Parkinson's disease, arthritis
07/03/2008US20080159989 Method of Promoting the Differentiation of Staminal Cells
07/03/2008US20080159987 Using bifidobacteria expressing rifamycin based non-sytemic antibiotic to treat nervous system disorders; probiotics
07/03/2008US20080159984 Compositions Capable of Facilitating Penetration Across a Biological Barrier
07/03/2008DE102007054788A1 Retard-Zusammensetzungen und Verfahren zu ihrer Herstellung Sustained-release compositions, and processes for their preparation
07/03/2008CA2790018A1 Formulations
07/03/2008CA2709428A1 Adp-ribosyl transferase fusion variant proteins
07/03/2008CA2674557A1 2-substituted-6-heterocyclic pyrimidone derivatives
07/03/2008CA2674518A1 Spiro-piperidine derivatives
07/03/2008CA2673921A1 Substituted isoquinolines and their use as rho-kinase inhibitors
07/03/2008CA2673736A1 Compounds and methods for kinase modulation, and indications therefor
07/03/2008CA2673601A1 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
07/03/2008CA2673472A1 5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
07/03/2008CA2673370A1 Substituted acetophenones useful as pde4 inhibitors
07/03/2008CA2673020A1 Spirocyclic azaadamantane derivatives and methods of use
07/03/2008CA2672750A1 Trkb agonists for treating autoimmune disorders
07/03/2008CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds
07/03/2008CA2672692A1 8-ethinylxanthine derivatives as selective a2a receptor antagonists
07/03/2008CA2672564A1 Substituted heteroaryl pyridopyrimidone derivatives
07/03/2008CA2672196A1 Antagonists of the trpv1 receptor and uses thereof
07/02/2008EP1939297A1 Alzheimer's disease secretase
07/02/2008EP1939291A2 Inhibitor oligonucleotides and their use for specific repression of a gene
07/02/2008EP1939204A1 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1939197A1 8-ethinylxanthine derivatives as selective A2A receptor antagonists
07/02/2008EP1939192A1 Cyclopentanone derivatives, method of synthesis and uses thereof
07/02/2008EP1939191A1 Furan derivatives, method of synthesis and uses thereof
07/02/2008EP1939187A1 Substituted heteroaryl pyridopyrimidone derivatives
1 ... 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 ... 1833